Literature DB >> 26989737

Determination of haptoglobin genotype in an Iranian population with idiopathic generalized epilepsy.

Sukaina Al-Balaghee1, Zeinab Al-Balaghee1, Ashraf Shabani1, Parinaz Ghadam1, Mojgan Bandehpour2, Ali Askari Mehr3, Bahram Kazemi2.   

Abstract

BACKGROUND: Haptoglobin (Hp) is a plasma α2-sialoglycoprotein that contains alpha and beta chains. It displays in three common phenotypes, Hp1-1, Hp2-1, and Hp2-2. Proteins expressed by polymorphic genes have grossly different molecular sizes resulting in different diffusion rates in the brain. Haptoglobin expressed by the Hp2-2 genotype has lower hemoglobin-binding capacity than Hp1-1 or Hp2-1 and is associated with idiopathic generalized epilepsy.
METHODS: To determine polymorphism in haptoglobin genes in patients with idiopathic generalized tonic-clonic seizures, 42 men, 42 women, and 50 controls were selected for this study. Genomic DNA was extracted from blood and studied by polymerase chain reactions (PCR).
RESULTS: The amplified fragments for the Hp1-1 and Hp2-2 genotypes were 1757 and 3481 base pairs (bp) respectively, and the Hp2-1 genotype had both fragments, in addition to a 349-bp fragment. The distribution of the three major Hp phenotypes in epilepsy patients was 28.6 (1-1), 38.1 (2-1), and 33.3% (2-2) in the men, and 31 (1-1), 40.5 (2-1), and 28.6% (2-2) in the women. The distribution of Hp genotypes in controls was 22 (1-1), 40 (2-1), and 38% (2-2).
CONCLUSION: We show that all Hp genotypes participate in idiopathic generalized epilepsy.

Entities:  

Keywords:  Epilepsy; Haptoglobin; Iran

Year:  2015        PMID: 26989737      PMCID: PMC4757041     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  23 in total

1.  Notation for serum-protein groups and the genes controlling their inheritance.

Authors:  O SMITHIES; N F WALKER
Journal:  Nature       Date:  1956-09-29       Impact factor: 49.962

2.  Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin.

Authors:  Y I Miller; S M Altamentova; N Shaklai
Journal:  Biochemistry       Date:  1997-10-07       Impact factor: 3.162

Review 3.  Haptoglobin polymorphism and body iron stores.

Authors:  Joris R Delanghe; Michel R Langlois
Journal:  Clin Chem Lab Med       Date:  2002-03       Impact factor: 3.694

4.  Gene action in the human haptoglobins. I. Dissociation into constituent polypeptide chains.

Authors:  O Smithies; G E Connell; G H Dixon
Journal:  J Mol Biol       Date:  1966-11-14       Impact factor: 5.469

5.  The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males.

Authors:  M R Langlois; M E Martin; J R Boelaert; C Beaumont; Y E Taes; M L De Buyzere; D R Bernard; H M Neels; J R Delanghe
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

6.  Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis.

Authors:  M C Cid; D S Grant; G S Hoffman; R Auerbach; A S Fauci; H K Kleinman
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Human haptoglobin structure and function--a molecular modelling study.

Authors:  F Polticelli; A Bocedi; G Minervini; P Ascenzi
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

8.  Haemoglobin binding with haptoglobin. Unequivocal demonstration that the beta-chains of human haemoglobin bind to haptoglobin.

Authors:  A L Kazim; M Z Atassi
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

Review 9.  Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging.

Authors:  Marianne Jensby Nielsen; Søren Kragh Moestrup
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

10.  Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism.

Authors:  Joris R Delanghe; Michel R Langlois; Marc L De Buyzere; Mathieu A Torck
Journal:  Clin Chem       Date:  2007-08       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.